Serge Belanger
Stock Analyst at Needham
(4.78)
# 558
Out of 4,509 analysts
1032
Total ratings
52%
Success rate
15.4%
Average return
Main Sectors:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMPH Amphastar Pharmaceuticals | Maintained: Hold | n/a | $19.29 | - | 44 | Jul 8, 2026 | |
| EOLS Evolus | Maintained: Hold | n/a | $6.52 | - | 30 | Jul 8, 2026 | |
| BCRX BioCryst Pharmaceuticals | Maintained: Buy | $16 | $9.91 | +61.45% | 57 | Jun 30, 2026 | |
| PCRX Pacira BioSciences | Maintained: Buy | $32 | $25.54 | +25.29% | 79 | Jun 30, 2026 | |
| ARQT Arcutis Biotherapeutics | Maintained: Buy | $36 | $27.12 | +32.74% | 34 | Jun 30, 2026 | |
| CYTK Cytokinetics | Maintained: Buy | $102 | $82.24 | +24.03% | 50 | Jun 29, 2026 | |
| VRDN Viridian Therapeutics | Maintained: Buy | $32 → $34 | $18.99 | +79.04% | 35 | Jun 29, 2026 | |
| OMER Omeros | Maintained: Hold | n/a | $10.01 | - | 53 | Jun 26, 2026 | |
| MLTX MoonLake Immunotherapeutics | Maintained: Buy | $30 | $20.41 | +46.99% | 25 | Jun 22, 2026 | |
| OCUL Ocular Therapeutix | Maintained: Buy | $18 | $9.88 | +82.19% | 14 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.4169 | - | 61 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $136 | $110.18 | +23.43% | 1 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 → $38 | $13.15 | +188.97% | 8 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $16.52 | +39.23% | 50 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $8.32 | +80.29% | 35 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.92 | - | 47 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.18 | - | 40 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 | $34.82 | +60.83% | 167 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 → $70 | $71.21 | -1.70% | 71 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $78 | $67.72 | +15.18% | 39 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $33.28 | +44.23% | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.249 | - | 48 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.38 | n/a | 9 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.8178 | n/a | 13 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $2.03 | n/a | 1 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.009 | n/a | 2 | Jun 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $5 | $0.05 | n/a | 3 | Aug 19, 2016 |
Amphastar Pharmaceuticals
Jul 8, 2026
Maintained: Hold
Price Target: n/a
Current: $19.29
Upside: -
Evolus
Jul 8, 2026
Maintained: Hold
Price Target: n/a
Current: $6.52
Upside: -
BioCryst Pharmaceuticals
Jun 30, 2026
Maintained: Buy
Price Target: $16
Current: $9.91
Upside: +61.45%
Pacira BioSciences
Jun 30, 2026
Maintained: Buy
Price Target: $32
Current: $25.54
Upside: +25.29%
Arcutis Biotherapeutics
Jun 30, 2026
Maintained: Buy
Price Target: $36
Current: $27.12
Upside: +32.74%
Cytokinetics
Jun 29, 2026
Maintained: Buy
Price Target: $102
Current: $82.24
Upside: +24.03%
Viridian Therapeutics
Jun 29, 2026
Maintained: Buy
Price Target: $32 → $34
Current: $18.99
Upside: +79.04%
Omeros
Jun 26, 2026
Maintained: Hold
Price Target: n/a
Current: $10.01
Upside: -
MoonLake Immunotherapeutics
Jun 22, 2026
Maintained: Buy
Price Target: $30
Current: $20.41
Upside: +46.99%
Ocular Therapeutix
Jun 18, 2026
Maintained: Buy
Price Target: $18
Current: $9.88
Upside: +82.19%
Jun 2, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.4169
Upside: -
Jun 2, 2026
Initiated Coverage: Buy
Price Target: $136
Current: $110.18
Upside: +23.43%
Jun 1, 2026
Maintained: Buy
Price Target: $46 → $38
Current: $13.15
Upside: +188.97%
May 20, 2026
Maintained: Buy
Price Target: $23
Current: $16.52
Upside: +39.23%
May 14, 2026
Maintained: Buy
Price Target: $15
Current: $8.32
Upside: +80.29%
May 13, 2026
Rated: Hold
Price Target: n/a
Current: $5.92
Upside: -
May 12, 2026
Maintained: Hold
Price Target: n/a
Current: $3.18
Upside: -
May 12, 2026
Maintained: Buy
Price Target: $56
Current: $34.82
Upside: +60.83%
May 11, 2026
Maintained: Buy
Price Target: $54 → $70
Current: $71.21
Upside: -1.70%
May 8, 2026
Maintained: Buy
Price Target: $80 → $78
Current: $67.72
Upside: +15.18%
May 7, 2026
Maintained: Buy
Price Target: $48
Current: $33.28
Upside: +44.23%
Dec 23, 2025
Rated: Hold
Price Target: n/a
Current: $0.249
Upside: -
Oct 28, 2022
Rated: Hold
Price Target: n/a
Current: $1.38
Upside: n/a
Oct 28, 2022
Rated: Hold
Price Target: n/a
Current: $0.8178
Upside: n/a
Nov 5, 2021
Maintained: Buy
Price Target: $22
Current: $2.03
Upside: n/a
Jun 26, 2017
Reiterated: Hold
Price Target: n/a
Current: $0.009
Upside: n/a
Aug 19, 2016
Reiterated: Buy
Price Target: $11 → $5
Current: $0.05
Upside: n/a